-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Mq9isCcy7LyagAdgrzdHgHACfRxL1ug0jIm4wrineGc0W7UBk1Lg/Kgts1a8drIC x46U+F6YgOzKDqOZPx9muw== 0000947871-02-001768.txt : 20020903 0000947871-02-001768.hdr.sgml : 20020903 20020903165111 ACCESSION NUMBER: 0000947871-02-001768 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020813 FILED AS OF DATE: 20020903 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIPID SCIENCES INC/ CENTRAL INDEX KEY: 0000071478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 430433090 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 02755526 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 925-249-4000 MAIL ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 FORMER COMPANY: FORMER CONFORMED NAME: NEW MEXICO & ARIZONA LAND CO DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NZ CORP DATE OF NAME CHANGE: 20000810 COMPANY DATA: COMPANY CONFORMED NAME: MEYER S LEWIS CENTRAL INDEX KEY: 0001050704 STANDARD INDUSTRIAL CLASSIFICATION: LOAN BROKERS [6163] DIRECTOR STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A BUSINESS ADDRESS: STREET 1: 3021 CITRUS CIRCLE STREET 2: SUITE 150 CITY: WALNUT CREEK STATE: CA ZIP: 94598 BUSINESS PHONE: 4156584150 MAIL ADDRESS: STREET 1: 235 MONTGOMERY STREET 750 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4/A 1 form4a_090302.txt AMENDMENT NO. 1 TO FORM 4
- ---------------- U.S. SECURITIES AND EXCHANGE COMMISSION |F O R M 4| WASHINGTON, D.C. 20549 - ---------------- [X] Check this box if no longer STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) - ------------------------------------------------------------------------------------------------------------------------------------ |1.Name and Address of Reporting Person |2.Issuer Name and Ticker or Trading Symbol |6.Relationship of Reporting Persons to | | | | Issuer (Check all applicable) | | | | | | Meyer S. Lewis | Lipid Sciences, Inc. (LIPD) | X Director 10% Owner | |----------------------------------------|------------------------------------------------|--- --- | | (Last) (First) (Middle) |3.IRS or Identification|4.Statement for Month/ | Officer Other | | | Number of Reporting | Year |---(give title below) ---(specify below)| | | Person, | | | | | (Voluntary) | | | | 5232 Springridge Way | | August 2002 | | |----------------------------------------| |------------------------|----------------------------------------| | (Street) | |5.If Amendment, Date of |7. Individual or Joint/Group Filing | | | | Original (Month/Year) | (Check Applicable Line) | | | | | | | | | | X Form filed by One Reporting Person | | | | |--- | | | | | Form filed by More than One | | Fairfield, California 94585 | | |--- Reporting Person | |----------------------------------------------------------------------------------------------------------------------------------| | (City) (State) (Zip) | | TABLE I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |----------------------------------------------------------------------------------------------------------------------------------| |1.Title of Security |2.Transac- |3.Trans- |4.Securities Acquired (A) or |5.Amount of |6.Owner- |7.Nature of | | (Instr. 3) | tion Date | action | Disposed of (D) | Securities | ship Form:| Indirect | | |(Month/Day/ | Code | (Instr. 3, 4 and 5) | Beneficially | Direct (D)| Beneficial | | | Year) | (Instr. 8) | | Owned at End | or | Ownership | | | |-------------|---------------------------------| of Month | Indirect | (Instr.4) | | | | | | Amount |(A) or | | (Instr. 3 & 4)| (I) | | | | | Code | V |(See Note 1) |(D) | Price | | (Instr. 4)| | |------------------------|------------|-------------|-------------|-------|-----------|----------------|------------|--------------| | | | | | | | | | | | | Common Stock | 08/05/02 | P | | 80,000 | A |$4.04/share| 80,000(8/14/02)| D | | - ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities owned directly or indirectly. (Over)
FORM 4 (continued) TABLE II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) - ------------------------------------------------------------------------------------------------------------------------------------ |1.Title of|2.Conver-|3.Trans-|4.Trans- |5.Number of |6.Date |7.Title and |8.Price of|9.Number|10. |11.Nat-| |Derivative|sion or | action | action | Derivative | Exercisable | Amount |Derivative|of |Owner-|ure of | |Security |Exercise | Date | Code | Securities | and | of |Security |Deriv- |ship |Indi- | |(Instr. 3)|Price of |(Month/ |(Instr.8)| Acquired (A) or | Expiration | Underlying |(Instr. 5)|ative |Form |rect | | |Deriva- | Day/ | | Disposed of (D) | Date | Securities | |Securi- |of |Bene- | | |tive | Year) | | (Instr. 3, 4 and | (Month/Day/ | (Instr. | |ties |Deriv-|ficial | | |Security | | | 5) | Year) | 3 and 4) | |Bene- |ative |Owner- | | | | | | | | | |ficially|Secu- |ship | | | | | | | | | |Owned at|rity: |(Instr.| | | | | | | | | |End of |Direct|4) | | | | | | | | | |Month |(D) or| | | | | | | | | | |(Instr. |In- | | | | | | | | | | |4) |direct| | | | | | | |-----------------|-----------------| | |(I) | | | | | | | |Date |Expir- | |Amount or| | |(In- | | | | | |---------|-------------------|Exer- |ation | |Number of| | |str. | | | | | | | | | |cisable |Date | Title |Shares | | |4) | | |----------|---------|--------|-----|---|---------|---------|--------|--------|-------|---------|----------|--------|------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | - ----------------------------------------------------------------------------------------------------------------------------------- Explanation of Responses: Lipid Sciences, Inc. ** Intentional misstatements or omissions of facts constitute Federal By: /s/ S. Lewis Meyer 8/13/02 Criminal Violations. --------------------------- ----------------- Name: S. Lewis Meyer Date Title: Director See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure.
-----END PRIVACY-ENHANCED MESSAGE-----